Share on StockTwits

CryoLife (NYSE:CRY) is scheduled to be issuing its Q114 quarterly earnings data on Tuesday, April 29th. Analysts expect the company to announce earnings of $0.07 per share and revenue of $37.30 million for the quarter. CryoLife has set its FY14 guidance at $0.21-0.24 EPS.Investors interested in listening to the company’s conference call can do so using this link.

CryoLife (NYSE:CRY) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.31 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.35 by $0.04. The company had revenue of $35.50 million for the quarter, compared to the consensus estimate of $34.90 million. On average, analysts expect CryoLife to post $0.26 EPS for the current fiscal year and $0.40 EPS for the next fiscal year.

CryoLife (NYSE:CRY) opened at 9.48 on Monday. CryoLife has a 52 week low of $5.65 and a 52 week high of $12.14. The stock’s 50-day moving average is $9.8 and its 200-day moving average is $9.94. The company has a market cap of $264.4 million and a price-to-earnings ratio of 16.99.

On the ratings front, analysts at Zacks downgraded shares of CryoLife from a “neutral” rating to an “underperform” rating in a research note on Wednesday, March 12th. They now have a $9.30 price target on the stock.

CryoLife, Inc (NYSE:CRY) is a biological medical device company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.